Mesa Laboratories Inc (MLAB)

Technology Scientific & Technical Instruments

100.80 $

-0.2% vs. previous close

Closing price · As of: 31. Jul 2026

Add to watchlist

Stock Watch

Stock Watch will tell you what changes at Mesa Laboratories Inc.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 5 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Insider Buying (Net) Institutional + Insiders Building Positions Institutional Accumulation Pros 80%

Momentum & Trend

Stan Weinstein: Stage 2

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Basics

Market Cap

0.6$B

Shares Outstanding

6Mio.

Float

89.2%

Beta

0.9

Performance

Perf. 1M

-3.30%

Perf. 3M

21.50%

Perf. 6M

23.80%

YTD Performance (%)

17.50%

52-Week-High Distance

-13.9%

Perf. 1Y

-2.80%

Perf. 3Y

-26.30%

Perf. 5Y

-63.38%

Valuation

P/E

86.9

Forward P/E

34.5

PEG

–

P/B

3.1

P/S

2.3

EV/EBITDA

15.5

Price/FCF

13.3

Profitability

Gross Margin

63.5%

EBIT Margin

–

Net Margin

2.7%

Return on Equity

3.9%

Return on Assets

2.7%

Balance Sheet & Safety

Equity Ratio

–

Debt/Equity

0.8

Altman Z″

3.64

Piotroski

6 out of 9

Growth

Sales Growth Last Quarter

2.60%

EPS Growth Last Quarter

-28.70%

Sales Growth (Year)

3.38%

Forward Sales Growth

5.02%

Forward EPS Growth

5.60%

Dividend

Dividend Yield

0.61%

Dividend Per Share (TTM)

0.64$

Payout Ratio

13.1%

Years Without a Cut

18Years

Increase Streak

0Years

Quality & Screener

Stage

RS Rating

EPS Rating

Piotroski

6 out of 9

Fundamental Rating

C (48 out of 100)

Altman Z″

3.64

AI Rating

–

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Analysts & Price Target

Current Price 100.80 $

Price Target (average) 112.00 $

The price target sits 11.1% above the current price.

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Next Reporting Date

4. Aug 2026 · Q2 2026

Expected Earnings per Share: 2.55 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

From To Indexed

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter	EPS (Earnings Per Share)	EPS YoY (%)	Sales ($M)	Sales YoY (%)	Net Margin (%)	OCF ($M)	FCF ($M)
2024: Q4	-0.31	-178.70	63	17.50	-2.70	18	18
2025: Q1	-1.31	–	62	5.50	-11.40	13	12
2025: Q2	0.85	36.70	60	2.40	8.00	2	1
2025: Q3	0.45	-28.60	61	5.00	4.10	8	7
2025: Q4	0.65	–	65	3.60	5.60	19	18
2026: Q1	-0.75	–	64	2.60	-6.50	14	17

What Do These Terms Mean?

EPS (Earnings Per Share):: Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):: Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:: All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:: What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):: The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):: Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

Mesa Laboratories, Inc. entwickelt, entwirft, fertigt, verkauft und wartet Life-Sciences-Werkzeuge und Qualitätskontrollprodukte und -dienstleistungen in Nordamerika, Europa, im asiatisch-pazifischen Raum und international.

Employees	717
Headquarters	Lakewood, CO
Website	mesalabs.com
IPO Date	25. Jan 1995

Management

Management
Name	Title	Birth Year
John V. Sakys C.P.A.	VP & CFO	1969
Brian David Archbold	Senior Vice President of Continuous Improvement	1975
Siddhartha Chandrakant Kadia B.E., M.S., Ph.D.	CEO, President & Director	1970
Lyndsey Crennen	Chief Accounting Officer	1985

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.